Latest filing published 23 Jun 2026 for Atea Pharmaceuticals, Inc.. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Polly A. Murphy (board member) discloses dealings in 2 companies, chiefly Atea Pharmaceuticals, Inc. and Celcuity Inc. Between 20 December 2021 and 18 June 2026, the trades on record add up to 6 filings.
Purchases make up the whole of the open-market record (2 purchases, €139k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 1 share grant and 3 option exercises.
The latest filing, published on 23 June 2026, reports an option exercise in Atea Pharmaceuticals, Inc. The last purchase on record was published on 23 November 2022, which is 1,425 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations